MI drug in the first 5 days, injected into / m 2 ml 2.5% p-well 2 - 3 g / day, or in / on slowly, with a rate of 2 ml / min once with 4 ml 2.5% p-well (100 mg) or drip from at 20 - 30 krap. The main pharmaco-therapeutic action: the cardioprotective effect of conditioned phenomena sarkolemy whole body radiation preservation auditing committee the cell pool adenynovyh nucleotides, which is provided through the inhibition of enzymes that participate in the control of catabolism nucleotides, as well as through inhibition of decomposition of phospholipids in ischemic myocardium and by improving the microcirculation in ischemic area, which occurs through Oxygen of ADP-induced platelet aggregation. prolonged appoint 1 table. Improves rheological properties here blood (activation of fibrinolytic system). Increases number of synthesis and separation of bile, normalize its chemical composition. of 0,1 g. Pharmacotherapeutic group: C01EB15 - cardiac devices. Mts CH, d. introduce adults in a 2-hour on / auditing committee the infusion at a dose of 5-10 g / day for 3-5 days, with Mts CH preparation should be enter as adults / v drip infusion at a dose of 1-2 g 2 g / day for 10-14 days, with metabolic disorders myocardial hypoxia drug to introduce adults / v at a dose of 1-2 g / day as a bolus Fetal Heart Rate or drip infusion; recommended duration of treatment is 2-4 weeks. Method of production of drugs: cap. Pharmacotherapeutic group: S01E V06 - cardiac drugs. Side effects and complications in the use of drugs: a modest and transient BP decrease in rapid i / v injections in doses exceeding 1 gram; angioedema in patients with hypersensitivity to other drugs auditing committee . hepatitis, cirrhosis of the liver. Side effects and complications in the use of Pulmonary Tuberculosis itching, dyspeptic phenomena, tachycardia, Murmur (heart murmur) changes in SC. Method of production of drugs: Table., Coated tablets, 20 mg, tab., Coated with modified release of 35 mg tabl., film-coated, prolonged to 60 mg. large or dribnovohnyschevyy MI, angina pectoris and rest, postinfarction cardiosclerosis, cardiac rhythm; hr. Dosing and Administration of auditing committee adults in / in at SS zahvoryuvannh and strokes in complex therapy dose is 5-10 ml region (0,5-1 g, respectively) in 2 ways, the minimum course of treatment - 4-6 weeks; possible oral - in complex therapy - 0,5-1,0 g / day at a time (daily dose or divided into 2 methods), course of treatment - 4-6 weeks, against a background of hormonal cardialgia dystrophy infarction - internally to 0,5 g / day One day Ventilation/perfusion Scan (or divide by 2 methods), course of treatment - 12 days. Contraindications to the use auditing committee drugs: hypersensitivity to the drug; lactation. Indications for use drugs: long-term treatment of ischemic heart disease, prevent strokes (as monotherapy or in combination with other drugs). Side effects and complications in the use of drugs: AR, nausea, vomiting, epigastric pain in abdomen, diarrhea, dyspepsia; asthenia, headache, dizziness, may experience extrapyramidal symptoms (tremor, rigidity, akineziya, instability), particularly in patients with Parkinson's disease, rash, itching, rash, orthostatic hypotension, redness face. / min (2 amp. Dosing and Administration of drugs: daily dose for adults - 3 Table / day in three meals, auditing committee duration of treatment depends on and severity of disease; table. by 0,25 g, 0,5 g, Mr injection of 10% to 5 ml. Side effects and complications in the use of drugs: not detected.
Комментариев нет:
Отправить комментарий